Insulin resistance, serum insulin and HOMA-R

被引:16
作者
Campanati, A. [1 ]
Ganzetti, G. [1 ]
Di Sario, A. [2 ]
Benedetti, A. [2 ]
Offidani, A. [1 ]
机构
[1] Polytech Univ Marche Reg, Dermatol Clin, Ancona, Italy
[2] Polytech Univ Marche Reg, Gastroenterol Clin, Ancona, Italy
关键词
Insulin Resistance; Metabolic Syndrome; Psoriasis; Etanercept; Fasting Plasma Glucose;
D O I
10.1007/s00535-013-0769-2
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
引用
收藏
页码:673 / 673
页数:1
相关论文
共 3 条
[1]   The effect of etanercept on hepatic fibrosis risk in patients with non-alcoholic fatty liver disease, metabolic syndrome, and psoriasis [J].
Campanati, A. ;
Ganzetti, G. ;
Di Sario, A. ;
Damiani, A. ;
Sandroni, L. ;
Rosa, L. ;
Benedetti, A. ;
Offidani, A. .
JOURNAL OF GASTROENTEROLOGY, 2013, 48 (07) :839-846
[2]   Preliminary report: homeostasis model assessment of insulin resistance, an indicator of insulin resistance, is strongly related to serum insulin: practical data presentation and the mathematical basis [J].
Kawada, Tomoyuki .
METABOLISM-CLINICAL AND EXPERIMENTAL, 2010, 59 (07) :1044-1046
[3]   Misclassification of subjects with insulin resistance and associated cardiovascular risk factors by homeostasis model assessment index. Utility of a postprandial method based on oral glucose tolerance test [J].
Martinez-Hervas, Sergio ;
Argente, Carlos ;
Garcia-Jodar, Javier ;
Priego, Antonia ;
Real, Jose T. ;
Carratala, Arturo ;
Carmena, Rafael ;
Ascaso, Juan F. .
METABOLISM-CLINICAL AND EXPERIMENTAL, 2011, 60 (05) :740-746